Erin McEvoy

GEM Health introduces GEM Daily Bite at Sprouts Farmers Markets, leveraging PLT’s Earthlight Whole Food Vitamin D.

BAPP releases new Laboratory Guidance Document to help supplement manufacturers optimize testing protocols and ensure cGMP compliance.

The randomized, double-blind, placebo-controlled crossover study showed short-term supplementation with the extract delivers dose-dependent benefits in both power output and brain focus.

The formulation blends micronized creatine, HMB, and pomegranate polyphenols for age-related muscle decline and support for cognition.

The systematic review noted beta-alanine consistently delays fatigue in female athletes.

The portfolio includes four mushroom blends targeting the energy, focus, immunity, and relaxation markets.

New research profiles a highly soluble short-chain oat fiber from one.bio that supports glycemic control and digestive health without the gritty texture of traditional fiber.

Oliver Catlin of BSCG calls on the dietary supplement industry to reinforce the boundary between lawful supplements and unapproved pharmaceutical drugs.

A new clinical study shows Caffinity, a whole coffee cherry extract from FutureCeuticals, boosts cycling performance by 4.6%.

A 12-week study demonstrated KSM-66 Ashwagandha root extract is well tolerated at 2,000 mg/day, maintaining normal liver, kidney, and thyroid parameters.

Organic matcha is combined with the company’s proprietary AlphaWave L-Theanine, reflecting consumer interest in energy without caffeine.

Explore the latest science on eye health supplements, the shift to lifelong foundational support, and how eye health and cognition support overlap.

Plant-based proteins provide ample opportunity to align with the increasing need for protein innovations.

CRN’s 2026 events will address supplement science communication, women’s health, innovation, and compliance for manufacturers.

From infant formula to healthy aging, eye health products are taking on a new dimension with benefit stacking and formulation into more complex matrices.

The partnership aims to open new formulation paths for the prebiotic for food, beverage, supplement, and pet nutrition brands.

A new Pharmaceutics study demonstrates how the dual-capsule technology delivers up to four times higher enzyme activity by protecting acid-sensitive nutrients from harsh stomach acids.

Kyowa Hakko to debut research on Cognizin Citicoline at ISSN 2026, revealing how a single 500 mg dose impacts acute cognitive performance and brain waves.

Learn how the official rename of the condition opens new opportunities for nutraceutical brands targeting systemic metabolic wellness.

Clinical research, botanical innovation, and targeted delivery formats are reshaping the menopause supplement market as nutraceutical companies develop science-backed solutions for sleep, muscle health, and women’s wellness.

Nutrafol Chief Medical Advisor Heather Woolery-Lloyd, MD, shares opportunities in women’s wellness, including skin health changes and addressing biological stressors behind hair thinning.

Dr. Thais Aliabadi, OBGYN, explains why the renaming of PCOS to PMOS is vital for addressing the root metabolic, endocrine, and whole-body health symptoms women face.

Study shows plant-based Ahiflower oil outperforms Echium oil in boosting tissue EPA and maintaining brain and heart DHA levels.

A NOW study of 28 lavender oils found 89% failed authenticity tests due to dilution, synthetic additives, and species substitution, linking low cost to poor quality.

Symrise and Probi expanded formulation horizons at Vitafoods Europe, launching stable postbiotics and clinical botanicals for active nutrition and wellness.

Arla Foods Ingredients introduced high-protein food and beverage concepts at Vitafoods Europe, targeting the fast-growing GLP-1 companion weight-management market.

In this preview of the upcoming The Outlook on Women's Wellness, Stacey Smith, DC, Senior Medical Science Liaison at Gnosis by Lesaffre, shares insights into product development for women's health solutions.

The 90% TG Premium fish oil with 900 mg/g EPA/DHA enables high-potency supplement formulations with smaller capsule sizes while maintaining sensory profiles.

The Food and Drug Administration has formalized a new post-market assessment process for chemicals used in food and simultaneously opened reassessments of butylated hydroxytoluene and azodicarbonamide.

The transition to Polyendocrine Metabolic Ovarian Syndrome (PMOS) signals a potential shift toward multisystem metabolic interventions in the women’s health category.